1. Respiratory disease in Niemann-Pick type C2 is caused by pulmonary alveolar proteinosis

Respiratory disease in Niemann-Pick type C2 is caused by pulmonary alveolar proteinosis

Prof. Matthias Griese, MD 1 Frank Brasch, MD 2 Ruth Aldana, MD 3 María de Lourdes Cabrera-Muñoz, MD 3 Uta Gölnitz, MD 4 Elina Ikonen, MD 5 José Karam Bechara, MD 3 Gerhard Liebisch, PhD 6 Matts D. Linder 5 Peter Lohse 1 Wolfgang Meyer, MD 7 Prof. Gerd Schmitz, MD 6 Asli Pamir, PhD 1 Jan Ripper, MD 1 Prof. Arndt Rolfs, MD 8 Andrea Schams 1 José Luis Lezana Fernández, MD 3
1 Ludwig-Maximilians-University of Munich 2 Hospital Bremen 3 Hospital Infantil de Mexico Federico Gomez 4 University of Rostock 5 University of Helsinki 6 University Hospital Regensburg 7 Queen Mary University of London 8 CENTOGENE AG
September 30, 2009

Clin Genet 2010: 77: 119 – 130.

Niemann-Pick diseases are hereditary neurovisceral lysosomal lipid storage disorders, of which the rare type C2 almost uniformly presents with respiratory distress in early infancy. In the patient presented here, the NPC2 exon 4 frameshift mutation c.408 409delAA caused reduced NPC2 protein levels in serum and lung lavage fluid and the synthesis of an aberrant, larger sized protein of around 28 kDa. Protein expression was strongly reduced also in alveolar macrophages. The infant developed failure to thrive and tachypnea. Lung lavage, computer tomography, and histology showed typical signs of pulmonary alveolar proteinosis with an abnormal intraalveolar accumulation of surfactant as well as macrophages. An NPC2-hypomorph animal model also showed pulmonary alveolar proteinosis and accumulation of macrophages in the lung, liver, and spleen long before the mice died. Due to the elevation of cholesterol, the surfactant had an abnormal composition and function. Despite the removal of large amounts of surfactant from the lungs by therapeutic lung lavages, this treatment was only temporarily successful and the infant died of respiratory failure. Our data indicate that respiratory distress in NPC2 disease is associated with a loss of normal NPC2 protein expression in alveolar macrophages and the accumulation of functionally inactive surfactant rich in cholesterol.